Hôpital Pasteur 2 - Service de Neurologie
Nice, 06001, France
NCT Number: NCT03279835
The objective of this prospective study is to evaluate the prevalence of neurocognitive impairments in HIV infected patients comparing patients with and without HAART. Recent studies have demonstrated a specific HIV infected patients neurocognitive disorders profile. These cognitive disorders concern primarily information processing speed, memory recall, attentional abilities, work related memory, executive functions, and psychometrical speed. This cognitive profile is similar to another highly documented one, described for another central nervous system disease (CNS): multiple sclerosis. In both CNS diseases, the earliest and most severe disorder is the one related to the information processing speed. For the multiple sclerosis patients, a short cognitive test (SDMT) is actually used not only to identify cognitive disorders presence, but also in order to predict a long term disability worsening. A digital version of this test (CSCT), has recently been developed in order to make this early evaluation easier. We hypothesize that CSCT alteration would also predict HAND, in HIV infected patients. A complete neuropsychological assessment is highly time and personal consuming. This short (approximatively 2 minutes) digital test would be highly helpful to identify patients, who will need a more extensive neuropsychological assessment.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Nice, 06001, France
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Symbol Digit Modalities Test (SDMT)
Cognitive Speed Computerized Test (CSCT)
Time frame: at patient inclusion
allows the evaluation of the speed of the processing of the information
Time frame: at patient inclusion
allows the evaluation of the overall cognitive functioning
Time frame: at patient inclusion
allows to evaluate the concentration capacity
Time frame: at patient inclusion
short-term memory evaluation and verbal working memory
Time frame: at patient inclusion
allows the evaluation of episodic and long-term verbal memory
Time frame: at patient inclusion
allows the evaluation of the long-term capacities of visio-construction (wealth score) and planning
Time frame: at patient inclusion
Assessment of Mental Flexibility
Time frame: at patient inclusion
allows the evaluation of the verbal initiation and verbal language capacities
Time frame: at patient inclusion
allows to evaluate the symptomatic character of the disorders
Centre Hospitalier Universitaire de Nice
Other
Acronym: NEURACog
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00980538
Blood-Borne Infections, Communicable Diseases
Los Angeles, California, United States
View Trial DetailsNCT02285114
HIV-1
Los Angeles, California, United States
View Trial DetailsNCT04442737
HIV-1
Birmingham, Alabama, United States
View Trial DetailsNCT02652260
Central Nervous System, HIV-1
View Trial Details